« Back to news listing

Abbott’s Bioresorbable Stent: Another Case of Innovation vs. FDA

Abbott Laboratories claimed the top honor in the medical devices category of the Wall Street Journal’s Innovation Awards this week with its highly anticipated bioresorbable vascular scaffold dubbed the Absorb. But this accolade for innovation inadvertently draws attention to a much larger debate currently dominating the medical device industry with just one sentence in the WSJ: “The company received approval this year to launch the stent in Europe and is aiming to get U.S. Food and Drug Administration approval in 2015.”

Read entire article: http://www.qmed.com/mpmn/medtechpulse/abbotts-bioresorbable-stent-another-case-innovation-vs-fda

« Back to news listing